Ledger. Australian venture funding, tracked

Clinician-Scientist, University of Adelaide

Professor Prash Sanders

Coverage

Stories naming Professor Prash Sanders. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $30m+

EBR Systems meets endpoints early in pivotal SOLVE-CRT trial: paves way for FDA approval application and commercialisation

Cardiac pacing company EBR Systems says its SOLVE-CRT trial hit its safety and efficacy goals early, keeping a 2024 US approval bid on course; the article also recalls its 2021 ASX listing.

Brandon Capital portfolio 22 May 2023 EBR SystemsAscension Saint Vincent Heart CenterBrandon BioCatalystCochlearCSLHarvard Medical SchoolMassachusetts General HospitalRoyal Adelaide HospitalUniversity of AdelaideBrandon CapitalHESTAHostplusM.H. Carnegie & CoTelstraSuperBill Ferris ACDr Jagmeet P. SinghJohn McCutcheonMary Norine (Minnow) WalshProfessor Prash Sanders

Also Brandon BioCatalyst portfolio

Something wrong? Tell us